{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:31:59Z","timestamp":1772803919788,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jcf.2021.01.003","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T16:09:55Z","timestamp":1611936595000},"page":"5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Re-evaluating aminoglycoside ototoxicity"],"prefix":"10.1016","volume":"20","author":[{"given":"Hinrich","family":"Staecker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcf.2021.01.003_bib0001","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a027029","article-title":"Aminoglycosides: An overview","volume":"6","author":"Krause","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jcf.2021.01.003_bib0002","series-title":"Annual data report to the center directors","article-title":"Cystic Fibrosis Foundation. Patient Registry","year":"2019"},{"key":"10.1016\/j.jcf.2021.01.003_bib0003","article-title":"Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin","volume":"20","author":"Garinis","year":"2020","journal-title":"J Cyst Fibr"},{"key":"10.1016\/j.jcf.2021.01.003_bib0004","article-title":"Ototoxicity in cystic fibrosis patients receiving intravenout tobramycin for acute pulmonary exacerbation","volume":"20","author":"Harruff","year":"2020","journal-title":"J Cyst Fibr"},{"key":"10.1016\/j.jcf.2021.01.003_bib0005","article-title":"The implementation of an aminoglycoside induced ototoxicity algorithm for people with cystic fibrosis","volume":"20","author":"Elson","year":"2020","journal-title":"J Cyst Fibr"},{"issue":"2","key":"10.1016\/j.jcf.2021.01.003_bib0006","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/14992027.2015.1094188","article-title":"Ototoxicity (cochleotoxicity) classifications: A review","volume":"55","author":"Crundwell","year":"2016","journal-title":"Int J Audiol [Internet]."},{"issue":"sup4","key":"10.1016\/j.jcf.2021.01.003_bib0007","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1080\/14992027.2017.1398421","article-title":"Applying U.S. national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions","volume":"57","author":"Konrad-Martin","year":"2018","journal-title":"Int J Audiol [Internet]"},{"issue":"8","key":"10.1016\/j.jcf.2021.01.003_bib0008","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/thoraxjnl-2019-214177","article-title":"Tablet and web-based audiometry to screen for hearing loss in adults with cystic fibrosis","volume":"75","author":"Vijayasingam","year":"2020","journal-title":"Thorax [Internet]"},{"issue":"1","key":"10.1016\/j.jcf.2021.01.003_bib0009","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/AUD.0000000000000746","article-title":"The Revised Hearing Handicap Inventory and Screening Tool Based on Psychometric Reevaluation of the Hearing Handicap Inventories for the Elderly and Adults","volume":"41","author":"Cassarly","year":"2020","journal-title":"Ear Hear [Internet]."},{"key":"10.1016\/j.jcf.2021.01.003_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/937861","article-title":"Mechanisms of Aminoglycoside Ototoxicity and Targets of Hair Cell Protection","volume":"2011","author":"Huth","year":"2011","journal-title":"Int J Otolaryngol"},{"key":"10.1016\/j.jcf.2021.01.003_bib0011","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fncel.2017.00308","article-title":"Aminoglycoside-induced cochleotoxicity: A review [Internet]. Vol. 11","author":"Jiang","year":"2017","journal-title":"Frontiers in Cellular Neuroscience. Frontiers Media S.A."},{"key":"10.1016\/j.jcf.2021.01.003_bib0012","article-title":"Ebselen attenuates tobramycin-induced ototoxicity in mice","volume":"20","author":"Gu","year":"2020","journal-title":"J Cyst Fibr"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199321000035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199321000035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:43:06Z","timestamp":1761601386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199321000035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1569199321000035"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2021.01.003","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-evaluating aminoglycoside ototoxicity","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2021.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}